Security key
98420P308
Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 96,692,530
- Share change
- -1,591,012
- Total reported value
- $42,834,946
- Price per share
- $0.44
- Number of holders
- 28
- Value change
- -$1,064,038
- Number of buys
- 9
- Number of sells
- 12
Report period
Q4 2024
Institutions
28
Top holders
10
XTNT full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Xtant Medical Holdings, Inc. SEC filings
Xtant Medical Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420P308
Recent filing periods:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
52%
|
73,114,592
|
$49,425,464 | — | 30 Sep 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
8.1%
|
11,394,000
|
$7,435,724 | — | 30 Sep 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
5.3%
|
7,415,413
|
$5,012,819 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
2,150,912
|
$1,454,017 | — | 30 Sep 2024 | |
| Juniper Investment Company, LLC |
13F
|
Company |
0.94%
|
1,318,944
|
$891,606 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.5%
|
694,208
|
$469,285 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
515,006
|
$348,225 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.21%
|
297,156
|
$200,878 | — | 30 Sep 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
293,500
|
$198,406 | — | 30 Sep 2024 | |
| Crescent Grove Advisors, LLC |
13F
|
Company |
0.15%
|
212,024
|
$143,328 | — | 30 Sep 2024 | |
| AMH Equity Ltd |
13F
|
Company |
0.14%
|
190,500
|
$128,778 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.09%
|
120,326
|
$81,340 | — | 30 Sep 2024 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.07%
|
100,000
|
$67,600 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
79,356
|
$53,645 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
58,666
|
$39,658 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
45,363
|
$30,665 | — | 30 Sep 2024 | |
| Evernest Financial Advisors, LLC |
13F
|
Company |
0.03%
|
40,000
|
$27,040 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
39,048
|
$26,397 | — | 30 Sep 2024 | |
| Midwest Professional Planners, LTD. |
13F
|
Company |
0.03%
|
35,744
|
$24,163 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
31,266
|
$21,136 | — | 30 Sep 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.02%
|
29,000
|
$19,604 | — | 30 Sep 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
24,102
|
$16,293 | — | 30 Sep 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
10,057
|
$6,799 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
5,317
|
$3,594 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
426
|
$288 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
111
|
$75 | — | 30 Sep 2024 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
0%
|
12
|
$7 | — | 30 Sep 2024 | |
| Matthew Rizzo |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Michael Eggenberg |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Kevin D. Brandt |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
943,736
|
$566,242 | — | 15 Aug 2024 | |
| Robert McNamara |
3/4/5
|
Director |
—
class O/S missing
|
754,151
|
$452,491 | — | 15 Aug 2024 | |
| Jeffrey J. Peters |
3/4/5
|
Director |
—
class O/S missing
|
448,546
|
$273,209 | — | 15 Aug 2022 | |
| D. Mitchell Keller |
3/4/5
|
Director |
—
class O/S missing
|
353,124
|
$211,874 | — | 15 Aug 2024 | |
| Greg Jensen |
3/4/5
|
Vice President, Finance & CFO |
—
mixed-class rows
|
477,639
mixed-class rows
|
$173,795 | — | 15 Aug 2021 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q4 2024
As of 31 Dec 2024,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,692,530 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, Altium Capital Management LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Crescent Grove Advisors, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and BlackRock, Inc..
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
27
Q4 2024 holders
28
Holder diff
1
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.